Find Trofinetide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 853400-76-7, Nnz-2566, Trofinetide [inn], Trofinetide [usan], Z2me8f52ql, L-glutamic acid, glycyl-2-methyl-l-prolyl-
Molecular Formula
C13H21N3O6
Molecular Weight
315.32  g/mol
InChI Key
BUSXWGRAOZQTEY-SDBXPKJASA-N
FDA UNII
Z2ME8F52QL

Trofinetide
Trofinetide (NNZ-2566), a neuroprotective analogue of [glypromate], is a novel molecule that has a profile suitable for both intravenous infusion and chronic oral delivery. It is currently in development to treat traumatic brain injury.
1 2D Structure

Trofinetide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[(2S)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic acid
2.1.2 InChI
InChI=1S/C13H21N3O6/c1-13(5-2-6-16(13)9(17)7-14)12(22)15-8(11(20)21)3-4-10(18)19/h8H,2-7,14H2,1H3,(H,15,22)(H,18,19)(H,20,21)/t8-,13-/m0/s1
2.1.3 InChI Key
BUSXWGRAOZQTEY-SDBXPKJASA-N
2.1.4 Canonical SMILES
CC1(CCCN1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
C[C@]1(CCCN1C(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
Z2ME8F52QL
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Glycyl-l-2-methylprolyl-l-glutamic Acid

2.3.2 Depositor-Supplied Synonyms

1. 853400-76-7

2. Nnz-2566

3. Trofinetide [inn]

4. Trofinetide [usan]

5. Z2me8f52ql

6. L-glutamic Acid, Glycyl-2-methyl-l-prolyl-

7. Acp-2566

8. ((s)-1-glycyl-2-methylpyrrolidine-2-carbonyl)-l-glutamic Acid

9. Unii-z2me8f52ql

10. Nnz 2566

11. Glycyl-l-2-methylprolyl-l-glutamic Acid

12. Glycyl-2-methyl-l-prolyl-l-glutamic Acid

13. Trofinetide(nnz2566)

14. Trofinetide [who-dd]

15. Chembl197084

16. Schembl1170014

17. Gly-2-methyl-l-pro-l-glu-oh

18. Dtxsid101336041

19. Who 10076

20. Cs-8154

21. Db06045

22. Hy-16757

23. A16972

24. Q27294917

25. (2s)-2-[[(2s)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic Acid

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 315.32 g/mol
Molecular Formula C13H21N3O6
XLogP3-3.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass315.14303540 g/mol
Monoisotopic Mass315.14303540 g/mol
Topological Polar Surface Area150 Ų
Heavy Atom Count22
Formal Charge0
Complexity480
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in traumatic brain injuries.


5 Pharmacology and Biochemistry
5.1 Pharmacology

NNZ-2566 is shown to have multi-faceted action to significantly reduce both inflammation and apoptosis (cell death), protecting the neurons and their surrounding infrastructure.


API SUPPLIERS

read-more
read-more

01

Seqens

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Compamed
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Seqens Company Banner

02

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty